Drugs / Fu Tiankang
last change Dec 2017 re-read 9 days ago

Fu Tiankang

Developed for
vulvar intraepithelial neoplasia
Investigated by
Jinan Military General Hospital

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02890277 Jan 2016 → Dec 2017 vulvar intraepithelial neoplasia Jinan Military General Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fu Tiankang ClinicalTrials.gov intervention name — accepted as the source's own label NCT02890277 ↗